Navigation Links
CoLucid Pharmaceuticals and ILDONG Pharmaceutical Enter into a Distribution and Supply Agreement for Lasmiditan, a Novel Agent for Acute Migraine
Date:10/22/2013

; It selectively targets 5-HT1F receptors expressed in the trigeminal pathway.  Its novel chemical class and differentiated site and mechanism of action led to Lasmiditan's designation as a "ditan", a new drug class, by the INN.

CoLucid has successfully completed six clinical studies for Lasmiditan, including a Phase 2b study treating a single migraine attack in 391 patients, as well as a TQTc study.

Phase 3 development will address two major unmet needs in patients who are poorly served by currently available therapies:

  • Patients with risk factors for cardiovascular disease and those with cardiovascular disease
  • Patients who have not had adequate response to triptans

ABOUT MIGRAINE

Migraine is ranked as the seventh highest cause of global disability and in the top 10 causes of disability in 14 of 21 world regions studied, according to findings by the Global Burden of Disease Survey 2010 conducted by the World Health Organization. It is the leading cause of disability among neurological disorders.  Some 36 million Americans have migraine, more than have asthma or diabetes combined.  Migraine can be extremely disabling and costly, accounting for more than $20 billion in direct (e.g. doctor visits, medications) and indirect (e.g. missed work, lost productivity) expenses each year in the United States. The prevalence of migraine in Asia is approximately 9%, and in South Korea alone, it is 6%.  According to statistics available from the Health and Insurance Review Agency (HIRA), in 2012 more than 500,000 patients were diagnosed with migraine in Korea, with women accounting for 72% of these numbers.

ABOUT COLUCID PHARMACEUTICALS, INC.

CoLucid was founded in 2005 by Pappas Ventures to advance innovative drug candidates with the potential to provide
'/>"/>

SOURCE CoLucid Pharmaceuticals, Inc; ILDONG Pharmaceutical Co., Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CoLucid Pharmaceuticals Details Phase 3 Development Strategy for Lasmiditan to Address Major Unmet Needs in Acute Migraine Therapy
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
4. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
5. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
6. Icahn Issues Statement Regarding Amylin Pharmaceuticals
7. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
8. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
9. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
10. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
11. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... -- Shire plc (LSE: SHP, NASDAQ: ... Fair Trading (OFT) approval condition to the announced tender offer ... VPHM).   As a result of the waiver, ... Shire expects to complete the tender offer on January 24, ... satisfaction of all of the remaining conditions to the tender ...
(Date:1/15/2014)... 2014 Tegra Medical is very pleased to ... as its new Chief Executive Officer.  Mark was ... in which he has overseen the company,s four facilities ... , and Costa Rica.  Mr. King joined Tegra ... sales, engineering and manufacturing experience in medical device businesses, ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... market research report is available in its ... Market & Forecast – Worldwide Analysis ... Insulin Pump Market Analysis ... in the market as insulin delivery systems ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
(Date:4/14/2014)... COLUMBUS, Ohio Heart patients with beliefs about health ... to skip sessions of cardiac rehabilitation, new research suggests. ... number of these beliefs referred to as "irrational ... was associated with lower adherence to a prescribed ... assessed: Doubting the preventive power of the flu vaccine ...
(Date:4/14/2014)... A new study shows that domestic abuse is ... depression and post-traumatic stress disorder (PTSD), in mothers. ... abuse are associated with specific mental health problems. ... Carolina State University, Simon Fraser University and the ... see whether and how intimate partner abuse ...
(Date:4/14/2014)... to treatment guidelines for high-risk bladder cancer, chemotherapy ... in routine clinical practice. The findings are published ... journal of the American Cancer Society. , Clinical ... patients with muscle-invasive bladder cancer who are given ... whether chemotherapy after surgery also improves survival. To ...
(Date:4/13/2014)... force has created a new definition for epilepsy that ... disease. The study published in Epilepsia , a ... League Against Epilepsy (ILAE), provides a greater level of ... unprovoked seizures, and those with one unprovoked seizure and ... , The 2005 report by the ILAE task force ...
(Date:4/11/2014)... there is still no effective medical treatment. In an ... of a schizophrenic person, researchers from the University of ... rats that have been given hallucinogenic drugs. This may ... Seven per cent of the adult population suffers from ... understand the disease, they still do not know what ...
Breaking Medicine News(10 mins):Health News:Irrational health beliefs linked to skipping cardiac rehab sessions 2Health News:Irrational health beliefs linked to skipping cardiac rehab sessions 3Health News:Study links domestic abuse to mental health problems in new mothers 2Health News:New clinical definition for epilepsy improves diagnosis accuracy 2Health News:Protein researches closing in on the mystery of schizophrenia 2Health News:Protein researches closing in on the mystery of schizophrenia 3
... say , WEDNESDAY, Nov. 14 (HealthDay News) -- U.S. scientists ... in cancer cells. , They found that genes in cancer ... structures called nucleosomes within the cells. , "The study shows ... in cancer cells. It identifies what the target looks like, ...
... other partners and donors share in success, ... National,Pediatric Brain Tumor Consortium headquarters, Chili,s Care ... for exceptional patient care, MEMPHIS, Tenn., Nov. ... Grill & Bar(R) celebrated the national,grand opening of ...
... Toy Drive to Benefit Shands Jacksonville-Marks Grand Opening ... Bank will,officially dedicate its new Mandarin branch today ... will attend the,grand opening event this morning, which ... opening of the facility and the,Company,s expanded presence ...
... With half of dogs and cats over age 10 dying of cancer, ... free oncology consultations ... any pet., BOISE, Idaho, Nov. 14 When Jack Stephens, DVM, ... emotional support from his small dog, Spanky. Recognizing that,cancer now claims the ...
... Be Held in Conjunction with Inaugural Gala, NORTH ... the National Patient Safety Foundation today announced that it ... 7-8, 2008 in,Boston, Massachusetts. The Institute, established by NPSF ... strategic paths and calls to action for,the field of ...
... initials? Most people do and, as past research has shown, ... For example, Jack is more likely to move to Jacksonville ... to move to Philadelphia and marry Phyllis. Scientists call this ... enough to encourage the pursuit of name-resembling life outcomes and ...
Cached Medicine News:Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 2Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 3Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 4Health News:CapitalSouth Bank Officially Opens Three of Four New Locations in Jacksonville 2Health News:CapitalSouth Bank Officially Opens Three of Four New Locations in Jacksonville 3Health News:All Pets With Cancer in U.S. Provided Free Consultation 2Health News:All Pets With Cancer in U.S. Provided Free Consultation 3Health News:All Pets With Cancer in U.S. Provided Free Consultation 4Health News:Lucian Leape Institute Announces First Roundtable 2Health News:Lucian Leape Institute Announces First Roundtable 3Health News:What's in a name? Initials linked to success, study shows 2
... accommodate a variety of applications across a ... DestinyPlus is suitable for any laboratory demanding ... a mixed-mode throughput exceeding 95 PT/aPTT/Fibrinogen per ... full range of chromogenics, the AMAX DestinyPlus ...
Non-invasive and continuous tcpCO2 and tcpO2 patient monitoring....
Two separate sensors provide continuous measurement of tcpO2/tcpCO2 and SpO2....
... components that comprise the SmartPill GI ... comprise the SmartPill GI Monitoring System: ... Receiver software and SmartPill MotiliGI software. ... indispensable parts of the SmartPill GI ...
Medicine Products: